NovaVive Inc. (Canada)
Settle® immunotherapy for equine endometritis is now available in Canada. It's also sold in the USA, Australia, New Zealand and UAE. Settle is compatible with conventional treatments and is safe with natural breeding or AI.
Basic Information
- Category: business
- Website: https://novavive.ca
Documented Facts
- Email: info@novavive.ca (No linked source recorded for this statement.)
Evidence and Sources
- NovaVive Inc. (Canada) — Official Site (official)
- NovaVive Inc. (Canada) on facebook (social)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about NovaVive Inc. (Canada).
- Canonical profile: https://brandsource.ai/brands/novavive-inc-canada
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/novavive-inc-canada/json-ld
- Citation profile API: https://brandsource.ai/api/brands/novavive-inc-canada/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (81/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Settle® immunotherapy for equine endometritis is now available in Canada. It's also sold in the USA, Australia, New Zealand and UAE. Settle is compatible with conventional treatments and is safe with natural breeding or AI.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 1 supporting source linked.
- 1 structured fact available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.